Global and China Epilepsy Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Epilepsy Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Partial/focal Seizure
- 1.2.3 Generalized Seizure
- 1.2.4 Myoclonus Misses
- 1.2.5 Negative Myoclonus
- 1.2.6 Eyelid Myoclonus
- 1.2.7 Laughter
- 1.2.8 Others
- 1.3 Market by Application
- 1.3.1 Global Epilepsy Market Share by Application: 2020 VS 2026
- 1.3.2 Hospitals
- 1.3.3 Neurology Centers
- 1.3.4 Home Care Settings
- 1.3.5 Ambulatory Surgical Centers
- 1.3.6 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Epilepsy Market Perspective (2015-2026)
- 2.2 Global Epilepsy Growth Trends by Regions
- 2.2.1 Epilepsy Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Epilepsy Historic Market Share by Regions (2015-2020)
- 2.2.3 Epilepsy Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Epilepsy Players by Market Size
- 3.1.1 Global Top Epilepsy Players by Revenue (2015-2020)
- 3.1.2 Global Epilepsy Revenue Market Share by Players (2015-2020)
- 3.2 Global Epilepsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Epilepsy Revenue
- 3.4 Global Epilepsy Market Concentration Ratio
- 3.4.1 Global Epilepsy Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Revenue in 2019
- 3.5 Key Players Epilepsy Area Served
- 3.6 Key Players Epilepsy Product Solution and Service
- 3.7 Date of Enter into Epilepsy Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Epilepsy Breakdown Data by Type (2015-2026)
- 4.1 Global Epilepsy Historic Market Size by Type (2015-2020)
- 4.2 Global Epilepsy Forecasted Market Size by Type (2021-2026)
5 Epilepsy Breakdown Data by Application (2015-2026)
- 5.1 Global Epilepsy Historic Market Size by Application (2015-2020)
- 5.2 Global Epilepsy Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Epilepsy Market Size (2015-2026)
- 6.2 North America Epilepsy Market Size by Type (2015-2020)
- 6.3 North America Epilepsy Market Size by Application (2015-2020)
- 6.4 North America Epilepsy Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Epilepsy Market Size (2015-2026)
- 7.2 Europe Epilepsy Market Size by Type (2015-2020)
- 7.3 Europe Epilepsy Market Size by Application (2015-2020)
- 7.4 Europe Epilepsy Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Epilepsy Market Size (2015-2026)
- 8.2 China Epilepsy Market Size by Type (2015-2020)
- 8.3 China Epilepsy Market Size by Application (2015-2020)
- 8.4 China Epilepsy Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Epilepsy Market Size (2015-2026)
- 9.2 Japan Epilepsy Market Size by Type (2015-2020)
- 9.3 Japan Epilepsy Market Size by Application (2015-2020)
- 9.4 Japan Epilepsy Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Epilepsy Market Size (2015-2026)
- 10.2 Southeast Asia Epilepsy Market Size by Type (2015-2020)
- 10.3 Southeast Asia Epilepsy Market Size by Application (2015-2020)
- 10.4 Southeast Asia Epilepsy Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11Key Players Profiles
- 11.1 LivaNova
- 11.1.1 LivaNova Company Details
- 11.1.2 LivaNova Business Overview
- 11.1.3 LivaNova Epilepsy Introduction
- 11.1.4 LivaNova Revenue in Epilepsy Business (2015-2020))
- 11.1.5 LivaNova Recent Development
- 11.2 Johnson & Johnson Services
- 11.2.1 Johnson & Johnson Services Company Details
- 11.2.2 Johnson & Johnson Services Business Overview
- 11.2.3 Johnson & Johnson Services Epilepsy Introduction
- 11.2.4 Johnson & Johnson Services Revenue in Epilepsy Business (2015-2020)
- 11.2.5 Johnson & Johnson Services Recent Development
- 11.3 Eisai
- 11.3.1 Eisai Company Details
- 11.3.2 Eisai Business Overview
- 11.3.3 Eisai Epilepsy Introduction
- 11.3.4 Eisai Revenue in Epilepsy Business (2015-2020)
- 11.3.5 Eisai Recent Development
- 11.4 GlaxoSmithKline PLC
- 11.4.1 GlaxoSmithKline PLC Company Details
- 11.4.2 GlaxoSmithKline PLC Business Overview
- 11.4.3 GlaxoSmithKline PLC Epilepsy Introduction
- 11.4.4 GlaxoSmithKline PLC Revenue in Epilepsy Business (2015-2020)
- 11.4.5 GlaxoSmithKline PLC Recent Development
- 11.5 Pfizer
- 11.5.1 Pfizer Company Details
- 11.5.2 Pfizer Business Overview
- 11.5.3 Pfizer Epilepsy Introduction
- 11.5.4 Pfizer Revenue in Epilepsy Business (2015-2020)
- 11.5.5 Pfizer Recent Development
- 11.6 UCB SA
- 11.6.1 UCB SA Company Details
- 11.6.2 UCB SA Business Overview
- 11.6.3 UCB SA Epilepsy Introduction
- 11.6.4 UCB SA Revenue in Epilepsy Business (2015-2020)
- 11.6.5 UCB SA Recent Development
- 11.7 Medtronic PLC (Ireland)
- 11.7.1 Medtronic PLC (Ireland) Company Details
- 11.7.2 Medtronic PLC (Ireland) Business Overview
- 11.7.3 Medtronic PLC (Ireland) Epilepsy Introduction
- 11.7.4 Medtronic PLC (Ireland) Revenue in Epilepsy Business (2015-2020)
- 11.7.5 Medtronic PLC (Ireland) Recent Development
- 11.8 NeuroPace
- 11.8.1 NeuroPace Company Details
- 11.8.2 NeuroPace Business Overview
- 11.8.3 NeuroPace Epilepsy Introduction
- 11.8.4 NeuroPace Revenue in Epilepsy Business (2015-2020)
- 11.8.5 NeuroPace Recent Development
- 11.9 Novartis AG
- 11.9.1 Novartis AG Company Details
- 11.9.2 Novartis AG Business Overview
- 11.9.3 Novartis AG Epilepsy Introduction
- 11.9.4 Novartis AG Revenue in Epilepsy Business (2015-2020)
- 11.9.5 Novartis AG Recent Development
- 11.10 GW Pharmaceuticals
- 11.10.1 GW Pharmaceuticals Company Details
- 11.10.2 GW Pharmaceuticals Business Overview
- 11.10.3 GW Pharmaceuticals Epilepsy Introduction
- 11.10.4 GW Pharmaceuticals Revenue in Epilepsy Business (2015-2020)
- 11.10.5 GW Pharmaceuticals Recent Development
- 11.11 Abbott Laboratories
- 10.11.1 Abbott Laboratories Company Details
- 10.11.2 Abbott Laboratories Business Overview
- 10.11.3 Abbott Laboratories Epilepsy Introduction
- 10.11.4 Abbott Laboratories Revenue in Epilepsy Business (2015-2020)
- 10.11.5 Abbott Laboratories Recent Development
- 11.12 Sanofi
- 10.12.1 Sanofi Company Details
- 10.12.2 Sanofi Business Overview
- 10.12.3 Sanofi Epilepsy Introduction
- 10.12.4 Sanofi Revenue in Epilepsy Business (2015-2020)
- 10.12.5 Sanofi Recent Development
- 11.13 Sunovion Pharmaceuticals
- 10.13.1 Sunovion Pharmaceuticals Company Details
- 10.13.2 Sunovion Pharmaceuticals Business Overview
- 10.13.3 Sunovion Pharmaceuticals Epilepsy Introduction
- 10.13.4 Sunovion Pharmaceuticals Revenue in Epilepsy Business (2015-2020)
- 10.13.5 Sunovion Pharmaceuticals Recent Development
- 11.14 Bausch Health
- 10.14.1 Bausch Health Company Details
- 10.14.2 Bausch Health Business Overview
- 10.14.3 Bausch Health Epilepsy Introduction
- 10.14.4 Bausch Health Revenue in Epilepsy Business (2015-2020)
- 10.14.5 Bausch Health Recent Development
- 11.15 Takeda
- 10.15.1 Takeda Company Details
- 10.15.2 Takeda Business Overview
- 10.15.3 Takeda Epilepsy Introduction
- 10.15.4 Takeda Revenue in Epilepsy Business (2015-2020)
- 10.15.5 Takeda Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Global Epilepsy Scope and Market Size
Epilepsy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Epilepsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Partial/focal Seizure
Generalized Seizure
Myoclonus Misses
Negative Myoclonus
Eyelid Myoclonus
Laughter
Others
Market segment by Application, split into
Hospitals
Neurology Centers
Home Care Settings
Ambulatory Surgical Centers
Others
Based on regional and country-level analysis, the Epilepsy market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Epilepsy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
LivaNova
Johnson & Johnson Services
Eisai
GlaxoSmithKline PLC
Pfizer
UCB SA
Medtronic PLC (Ireland)
NeuroPace
Novartis AG
GW Pharmaceuticals
Abbott Laboratories
Sanofi
Sunovion Pharmaceuticals
Bausch Health
Takeda